Hc Financial Advisors »

Crispr Therapeutics shares owned by Hc Financial Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Hc Financial Advisors from 13F filings

Historical chart of Hc Financial Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Hc Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Hc Financial Advisors

Quarter filed Position value Share count Share price at filing
2022-06-30 $15k 250 60.00
2022-03-31 $16k 250 64.00
2021-12-31 $19k 250 76.00
2021-09-30 $28k 250 112.00